Use of BNP levels in monitoring hospitalized heart failure patients with heart failure

Heart Failure Reviews

Volumn 8, Issue 4, 2003, Pages 339-344

  Maisel, Alan S ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; NESIRITIDE; NITROPRUSSIDE SODIUM; SPIRONOLACTONE; VASODILATOR AGENT;

FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HOME CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LUNG WEDGE PRESSURE; MORBIDITY; MORTALITY; OUTPATIENT CARE; PATIENT MONITORING; PEPTIDE ANALYSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW;

HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS;

EID: 0346264801     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026139130208     Document Type: Review

References (13)

1. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
2. Konstam MA, Kimmelstiel CD. Economics of heart failure. In: Balady GJ, Pina IL, eds. Exercise and Heart Failure. Armonk, NY: Futura, 1997:19-281.
3. Adams KF. Post hoc sub-group analysis and the truth of a clinical trial. Am Heart J 1998;136:751-758.
4. Cheng VL, Krishnaswamy P, Kazanegra R, et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol 2001;37:386-391.
5. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure. Am J Med 2002;113(3):215-219.
6. Kazanagra R, Chen V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel AS. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Card Failure 2001;7:21-29.
7. Maisel A. Algorithms for using B-type natriuretic peptide levels in the diagnosis and management of congestive heart failure. Critical Pathways in Card 2002;1(2):67-73.
8. Sodian R, Loebe M, Schmitt C, Potapov EV, Siniawski H, Muller J, Hausmann H, Zurbruegg HR, Weng Y, Hetzer R. Decreased plasma concentrations of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiology 2001;38:1942-1949.
9. Abraham WT, Lows BD, Ferguson DA, Odom J, Kim JK, Roberston AD, Bristow MR, Schrier RW. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Cardiac Failure 1998;4(1):37-44.
10. Publication Committee for the VMAC Investigators. Intravenous nesiritide versus nitroglycerin for the treatment of decompensated congestive heart failure - A randomized controlled trial. JAMA 2002;287(12):1531-1540.
11. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Reviews in Cardiovasc Med 2002;3(Suppl 4):S18-S27.
12. Emerman CL. Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Reviews in Cardiovasc Med 2002;3(Suppl 4):S28-S34.
13. Berger Circulation 2002;105:2392-2397.